How to Address Increasing Neurofilament Light Chain Levels

Opinion
Video

This program is supported by Novartis Pharmaceuticals Corporation. Content is independently developed by CMSC.

Tanuja Chitnis, MD, shares possible course of action if NFL levels begin to rise during treatment.

Tanuja Chitnis, MD, expresses a preference for conducting an MRI and personally examining the patient to gather a comprehensive understanding of the situation. She emphasizes the need to identify potential asymptomatic new changes on the neurological exam. Additionally, she acknowledges that the level of comfort and confidence in interpreting NFL changes may evolve in the future.

Video synopsis is AI-generated and reviewed by HCPLive® editorial staff.

This program is supported by Novartis Pharmaceuticals Corporation. Content is independently developed by CMSC.
Related Videos
Patricia K. Coyle, MD
Video 2 - 5 KOLs are featured in "Natural History of Spinal Muscular Atrophy"
Video 1 - 5 KOLs are featured in "Clinical Features and Phenotypes of Spinal Muscular Atrophy"
Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN
Kathy Zackowski, PhD, OTR
A panel of 3 experts on Alzheimer's disease
A panel of 3 experts on Alzheimer's disease
© 2024 MJH Life Sciences

All rights reserved.